TG Therapeutics, Inc. (TGTX) Presents at Cantor Global Healthcare Conference 2025 TranscriptSeeking Alpha • 09/04/25
TG Therapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment ConferenceGlobeNewsWire • 09/04/25
Why Is TG Therapeutics (TGTX) Up 4.7% Since Last Earnings Report?Zacks Investment Research • 09/03/25
TG Therapeutics Announces Completion of Existing Share Repurchase Program and Authorization of New $100 Million ProgramGlobeNewsWire • 09/03/25
Why Top 3% Stock TG Therapeutics Crashed Despite Raising Its 2025 OutlookInvestors Business Daily • 08/04/25
TG Therapeutics Reports Second Quarter 2025 Financial Results and Raises BRIUMVI Revenue GuidanceGlobeNewsWire • 08/04/25
TG Therapeutics to Host Conference Call on Second Quarter 2025 Financial Results and Business UpdateGlobeNewsWire • 07/30/25
TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q2 ReleaseZacks Investment Research • 07/29/25
TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare ConferenceGlobeNewsWire • 06/06/25
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual MeetingGlobeNewsWire • 05/27/25
TG Therapeutics: Share Price Slip On Q1 Earnings Unsurprising Given ChallengesSeeking Alpha • 05/05/25
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue GuidanceGlobeNewsWire • 05/05/25
TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business UpdateGlobeNewsWire • 04/30/25
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual MeetingGlobeNewsWire • 04/10/25